


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app42.us.archive.org';v.server_ms=217;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712204052im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712204052im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712204052im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712204052im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712204052/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712204052im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712204052cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712204052js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712204052if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204052/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712204052if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204052/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712204052/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712204052/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712204052/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712204052/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712204052/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712204052/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712204052/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712204052/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712204052/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712204052/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712204052/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712204052/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712204052/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712204052/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712204052/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712204052/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712204052/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712204052/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712204052/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010032</li>
            <li>2013 Aug
            </li>            
                                </ul>
        <div>
                <h1>Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712204052/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20Association%20for%20the%20Study%20of%20Liver%20Diseases&amp;fLockTerm=American%2BAssociation%2Bfor%2Bthe%2BStudy%2Bof%2BLiver%2BDiseases">American Association for the Study of Liver Diseases</a></li>
                        <li>   
                                <a id="1210" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
        <li><a href="/web/20180712204052/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20Society%20of%20Transplantation&amp;fLockTerm=American%2BSociety%2Bof%2BTransplantation">American Society of Transplantation</a></li>
                        <li>   
                                <a id="2358" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, Farmer D, Shemesh E, McDonald RA. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013 Aug;19(8):798-825. [321 references] <a href="https://web.archive.org/web/20180712204052/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23836431" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712204052im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table>                    <p><a href="/web/20180712204052/https://www.guideline.gov/Home/Disclaimer?id=47151&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fwww.aasld.org%252fpracticeguidelines%252fDocuments%252flt23697.pdf">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204052im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/search?f_Age_of_Target_Population=Child%20%282%20to%2012%20years%29&amp;fLockTerm=Child%2B%282%2Bto%2B12%2Byears%29">Child (2 to 12 years)</a></li>                      
                        <li><a href="/web/20180712204052/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712204052/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C0007222&amp;fLockTerm=Cardiovascular+disease%2c+unspecified">Cardiovascular disease, unspecified</a>
 (429.2), <a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C0018786&amp;fLockTerm=Hearing+examination%2c+not+otherwise+specified">Hearing examination, not otherwise specified</a>
 (95.42), <a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C0018786&amp;fLockTerm=Hearing+examination%2c+not+otherwise+specified">Hearing examination, not otherwise specified</a>
 (95.47), <a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C1318464&amp;fLockTerm=Occupational+therapy">Occupational therapy</a>
 (93.83), <a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C0023895&amp;fLockTerm=Unspecified+disorder+of+liver">Unspecified disorder of liver</a>
 (573.9), <a href="/web/20180712204052/https://www.guideline.gov/search?f_ICD9CM_CUI=C0036916&amp;fLockTerm=Venereal+disease%2c+unspecified">Venereal disease, unspecified</a>
 (099.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0085100&amp;fLockTerm=Adolescent+Health+Services">Adolescent Health Services</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C1720826&amp;fLockTerm=Adolescent+Nutritional+Physiological+Phenomena">Adolescent Nutritional Physiological Phenomena</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0001899&amp;fLockTerm=Alanine+Transaminase">Alanine Transaminase</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0005890&amp;fLockTerm=Body+Height">Body Height</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0005910&amp;fLockTerm=Body+Weight">Body Weight</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0007222&amp;fLockTerm=Cardiovascular+Diseases">Cardiovascular Diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0008079&amp;fLockTerm=Child+Health+Services">Child Health Services</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C1720755&amp;fLockTerm=Child+Nutritional+Physiological+Phenomena">Child Nutritional Physiological Phenomena</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0700589&amp;fLockTerm=Contraception">Contraception</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0011849&amp;fLockTerm=Diabetes+Mellitus">Diabetes Mellitus</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0017040&amp;fLockTerm=gamma-Glutamyltransferase">gamma-Glutamyltransferase</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0018129&amp;fLockTerm=Graft+Rejection">Graft Rejection</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0018786&amp;fLockTerm=Hearing+Tests">Hearing Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0019637&amp;fLockTerm=Histological+Techniques">Histological Techniques</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0020405&amp;fLockTerm=Hygiene">Hygiene</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0021079&amp;fLockTerm=Immunosuppression">Immunosuppression</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0021081&amp;fLockTerm=Immunosuppressive+Agents">Immunosuppressive Agents</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0022662&amp;fLockTerm=Kidney+Function+Tests">Kidney Function Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0023895&amp;fLockTerm=Liver+Diseases">Liver Diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0023901&amp;fLockTerm=Liver+Function+Tests">Liver Function Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0023911&amp;fLockTerm=Liver+Transplantation">Liver Transplantation</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0025345&amp;fLockTerm=Menstruation+Disturbances">Menstruation Disturbances</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0026933&amp;fLockTerm=Mycophenolic+Acid">Mycophenolic Acid</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C1318464&amp;fLockTerm=Occupational+Therapy">Occupational Therapy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C1321605&amp;fLockTerm=Patient+Compliance">Patient Compliance</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0033611&amp;fLockTerm=Protective+Clothing">Protective Clothing</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C1449702&amp;fLockTerm=Protein+Kinase+Inhibitors">Protein Kinase Inhibitors</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0034991&amp;fLockTerm=Rehabilitation">Rehabilitation</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0242550&amp;fLockTerm=Risk+Reduction+Behavior">Risk Reduction Behavior</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0036592&amp;fLockTerm=Self+Care">Self Care</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0036915&amp;fLockTerm=Sexuality">Sexuality</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0036916&amp;fLockTerm=Sexually+Transmitted+Diseases">Sexually Transmitted Diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0037831&amp;fLockTerm=Speech+Therapy">Speech Therapy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0038818&amp;fLockTerm=Sunscreening+Agents">Sunscreening Agents</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0085149&amp;fLockTerm=Tacrolimus">Tacrolimus</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C3178922&amp;fLockTerm=Transition+to+Adult+Care">Transition to Adult Care</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0042196&amp;fLockTerm=Vaccination">Vaccination</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MSH_CUI=C0042890&amp;fLockTerm=Vitamins">Vitamins</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0001899&amp;fLockTerm=Alanine+Transaminase">Alanine Transaminase</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0428327&amp;fLockTerm=ALT+blood+measurement">ALT blood measurement</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0201899&amp;fLockTerm=Aspartate+aminotransferase+measurement">Aspartate aminotransferase measurement</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C2237115&amp;fLockTerm=assessment+of+cognitive+functions">assessment of cognitive functions</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0344395&amp;fLockTerm=Bilirubin+measurement">Bilirubin measurement</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0193388&amp;fLockTerm=Biopsy+of+liver+(procedure)">Biopsy of liver (procedure)</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0005890&amp;fLockTerm=Body+Height">Body Height</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0005893&amp;fLockTerm=Body+mass+index+procedure">Body mass index procedure</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0005910&amp;fLockTerm=Body+Weight">Body Weight</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0007222&amp;fLockTerm=Cardiovascular+Diseases">Cardiovascular Diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0008079&amp;fLockTerm=Child+Health+Services">Child Health Services</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C1321605&amp;fLockTerm=Compliance+behavior">Compliance behavior</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0700589&amp;fLockTerm=Contraceptive+methods">Contraceptive methods</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0011849&amp;fLockTerm=Diabetes+Mellitus">Diabetes Mellitus</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0017040&amp;fLockTerm=Gamma-glutamyl+transferase">Gamma-glutamyl transferase</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0018129&amp;fLockTerm=Graft+Rejection">Graft Rejection</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0018786&amp;fLockTerm=Hearing+Tests">Hearing Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0020405&amp;fLockTerm=Hygiene">Hygiene</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0021081&amp;fLockTerm=Immunosuppressive+Agents">Immunosuppressive Agents</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0022662&amp;fLockTerm=Kidney+Function+Tests">Kidney Function Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0023895&amp;fLockTerm=Liver+diseases">Liver diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0023901&amp;fLockTerm=Liver+Function+Tests">Liver Function Tests</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0025345&amp;fLockTerm=Menstruation+Disturbances">Menstruation Disturbances</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0209368&amp;fLockTerm=mycophenolate+mofetil">mycophenolate mofetil</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0026933&amp;fLockTerm=Mycophenolic+Acid">Mycophenolic Acid</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C1318464&amp;fLockTerm=Occupational+therapy+regime">Occupational therapy regime</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C1449702&amp;fLockTerm=Protein+Kinase+Inhibitors">Protein Kinase Inhibitors</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0034991&amp;fLockTerm=Rehabilitation+therapy">Rehabilitation therapy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0036592&amp;fLockTerm=Self-care+interventions">Self-care interventions</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0036915&amp;fLockTerm=Sexuality">Sexuality</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0036916&amp;fLockTerm=Sexually+Transmitted+Diseases">Sexually Transmitted Diseases</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0037831&amp;fLockTerm=Speech+Therapy">Speech Therapy</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0038818&amp;fLockTerm=Sunscreening+Agents">Sunscreening Agents</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0085149&amp;fLockTerm=Tacrolimus">Tacrolimus</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0021079&amp;fLockTerm=Therapeutic+immunosuppression">Therapeutic immunosuppression</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0023911&amp;fLockTerm=Transplantation+of+liver">Transplantation of liver</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0042196&amp;fLockTerm=Vaccination">Vaccination</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_MTH_CUI=C0042890&amp;fLockTerm=Vitamins">Vitamins</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0005558&amp;fLockTerm=biopsies">biopsies</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0021079&amp;fLockTerm=immunosuppression">immunosuppression</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0023911&amp;fLockTerm=liver+transplantation">liver transplantation</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0209368&amp;fLockTerm=mycophenolate+mofetil">mycophenolate mofetil</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0036915&amp;fLockTerm=sexuality+and+reproductive+issues">sexuality and reproductive issues</a>
, <a href="/web/20180712204052/https://www.guideline.gov/search?f_PDQ_CUI=C0085149&amp;fLockTerm=tacrolimus">tacrolimus</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001899&amp;fLockTerm=Alanine+aminotransferase">Alanine aminotransferase</a>
 (56935002), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0428327&amp;fLockTerm=ALT+-+blood+measurement">ALT - blood measurement</a>
 (250637003), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0201899&amp;fLockTerm=Aspartate+aminotransferase+measurement">Aspartate aminotransferase measurement</a>
 (45896001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (252575000), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (32921008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (398171003), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (398280008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0344395&amp;fLockTerm=Bilirubin+measurement">Bilirubin measurement</a>
 (302787001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (129314006), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (86273004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0193388&amp;fLockTerm=Biopsy+of+liver">Biopsy of liver</a>
 (86259008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005890&amp;fLockTerm=Body+height+measure">Body height measure</a>
 (50373000), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005910&amp;fLockTerm=Body+weight">Body weight</a>
 (27113001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1720755&amp;fLockTerm=Child+nutrition">Child nutrition</a>
 (87346005), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1321605&amp;fLockTerm=Compliance+behavior">Compliance behavior</a>
 (405078008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0700589&amp;fLockTerm=Contraception">Contraception</a>
 (13197004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011849&amp;fLockTerm=Diabetes+mellitus">Diabetes mellitus</a>
 (73211009), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023895&amp;fLockTerm=Disease+of+liver">Disease of liver</a>
 (235856003), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0007222&amp;fLockTerm=Disorder+of+cardiovascular+system">Disorder of cardiovascular system</a>
 (49601007), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0025345&amp;fLockTerm=Disorder+of+menstruation">Disorder of menstruation</a>
 (289896006), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0025345&amp;fLockTerm=Disorder+of+menstruation">Disorder of menstruation</a>
 (386804004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0436149&amp;fLockTerm=Examination+of+skin">Examination of skin</a>
 (271303006), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0036915&amp;fLockTerm=Finding+related+to+sexual+state">Finding related to sexual state</a>
 (118200004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0017040&amp;fLockTerm=gamma-Glutamyltransferase">gamma-Glutamyltransferase</a>
 (60153001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018129&amp;fLockTerm=Graft+rejection">Graft rejection</a>
 (72627004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0455639&amp;fLockTerm=H%2fO%3a+tissue%2forgan+recipient">H/O: tissue/organ recipient</a>
 (161663000), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0264010&amp;fLockTerm=Hepatic+osteodystrophy">Hepatic osteodystrophy</a>
 (28193003), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021081&amp;fLockTerm=Immunosuppressant">Immunosuppressant</a>
 (372823004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021081&amp;fLockTerm=Immunosuppressant">Immunosuppressant</a>
 (69431002), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021079&amp;fLockTerm=Immunosuppressive+therapy">Immunosuppressive therapy</a>
 (86553008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1304734&amp;fLockTerm=Initial+psychiatric+assessment">Initial psychiatric assessment</a>
 (170679009), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023901&amp;fLockTerm=Liver+function+tests+-+general">Liver function tests - general</a>
 (26958001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023901&amp;fLockTerm=Liver+function+tests+-+general">Liver function tests - general</a>
 (271552009), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0400968&amp;fLockTerm=Liver+transplant+rejection">Liver transplant rejection</a>
 (235911006), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0209368&amp;fLockTerm=Mycophenolate+mofetil">Mycophenolate mofetil</a>
 (109131004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0209368&amp;fLockTerm=Mycophenolate+mofetil">Mycophenolate mofetil</a>
 (386976000), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026933&amp;fLockTerm=Mycophenolic+acid">Mycophenolic acid</a>
 (409330005), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026933&amp;fLockTerm=Mycophenolic+acid">Mycophenolic acid</a>
 (409331009), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1318464&amp;fLockTerm=Occupational+therapy">Occupational therapy</a>
 (84478008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1266827&amp;fLockTerm=Physical+rehabilitation+therapy+procedure">Physical rehabilitation therapy procedure</a>
 (108305003), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1449702&amp;fLockTerm=Protein+kinase+inhibitor">Protein kinase inhibitor</a>
 (426265004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1449702&amp;fLockTerm=Protein+kinase+inhibitor">Protein kinase inhibitor</a>
 (427510007), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0034991&amp;fLockTerm=Rehabilitation+therapy">Rehabilitation therapy</a>
 (52052004), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0022662&amp;fLockTerm=Renal+function+study">Renal function study</a>
 (44277000), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0036592&amp;fLockTerm=Self-care+interventions">Self-care interventions</a>
 (384758001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0036916&amp;fLockTerm=Sexually+transmitted+infectious+disease">Sexually transmitted infectious disease</a>
 (8098009), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0037831&amp;fLockTerm=Speech+therapy">Speech therapy</a>
 (5154007), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0038818&amp;fLockTerm=Sunscreen+agent">Sunscreen agent</a>
 (49663007), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085149&amp;fLockTerm=Tacrolimus">Tacrolimus</a>
 (109129008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085149&amp;fLockTerm=Tacrolimus">Tacrolimus</a>
 (386975001), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023911&amp;fLockTerm=Transplantation+of+liver">Transplantation of liver</a>
 (18027006), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0042890&amp;fLockTerm=Vitamin">Vitamin</a>
 (12968008), <a href="/web/20180712204052/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0042890&amp;fLockTerm=Vitamin">Vitamin</a>
 (87708000)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#430" class="section-mark">Contraindications</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/downloadcontent/ngc-10032?contentType=pdf" class="pdf">.PDF 101.9 kb</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/downloadcontent/ngc-10032?contentType=word" class="word">Word Document 298.7 kb</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/downloadcontent/ngc-10032?contentType=xml" class="xml">.XML 49.8 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204052/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/47151/longterm-medical-management-of-the-pediatric-patient-after-liver-transplantation-2013-practice-guideline-by-the-american-association-for-the-study-of-liver-diseases-and-the-american-society-of-transplantation" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204052/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/47151/longterm-medical-management-of-the-pediatric-patient-after-liver-transplantation-2013-practice-guideline-by-the-american-association-for-the-study-of-liver-diseases-and-the-american-society-of-transplantation" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204052/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/47151/longterm-medical-management-of-the-pediatric-patient-after-liver-transplantation-2013-practice-guideline-by-the-american-association-for-the-study-of-liver-diseases-and-the-american-society-of-transplantation&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712204052/mailto:/?Subject=AHRQ: Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.&amp;body=https://www.guideline.gov/summaries/summary/47151/longterm-medical-management-of-the-pediatric-patient-after-liver-transplantation-2013-practice-guideline-by-the-american-association-for-the-study-of-liver-diseases-and-the-american-society-of-transplantation" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Aug 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151">RefWorks</a></li>
                            <li><a href="/web/20180712204052/https://www.guideline.gov/summaries/citedownload/47151?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="47151" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The grading system for the strength of recommendations (<strong>1</strong> or <strong>2</strong>) and the levels of evidence (<strong>A</strong>&ndash;<strong>C</strong>) is defined at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Routine Monitoring and Management</span></strong></p>
<p><strong>Growth and Nutritional Rehabilitation</strong></p>
<ol style="list-style-type: decimal;">
    <li>Optimize the nutritional status before and after liver transplantation (LT) (<strong>1B</strong>). </li>
    <li>To encourage growth, routine immunosuppression protocols should minimize steroid exposure during the first 6 to 12 months after transplantation (<strong>1A</strong>). </li>
    <li>Measure the height and weight to identify patients with growth impairment who may benefit from reduced steroid exposure (<strong>1B</strong>). </li>
    <li>Monitor the body mass index and consider obesity management (<strong>2C</strong>). </li>
</ol>
<p><strong>Endocrine and Bone Metabolism</strong></p>
<p><em>Hepatic Osteodystrophy</em></p>
<ol style="list-style-type: decimal;" start="5">
    <li>Monitor patients for persistent hepatic osteodystrophy, risk factors for fractures, and scoliosis (<strong>1B</strong>). </li>
    <li>Continue mineral and fat-soluble vitamin supplementation (especially D<sub>2</sub>, or D<sub>3</sub>) until vitamin D levels are normal (<strong>1B</strong>). </li>
</ol>
<p><strong>Psychosocial Development</strong></p>
<ol style="list-style-type: decimal;" start="7">
    <li>The follow-up of school-aged LT recipients should include an assessment of school functioning and school absence (<strong>1A</strong>). </li>
    <li>Be aware of posttraumatic stress disorder or other mental health issues and refer a patient for a formal psychiatric evaluation if significant symptoms are present (<strong>1B</strong>). </li>
</ol>
<p><strong>Neurocognitive Function</strong></p>
<ol style="list-style-type: decimal;" start="9">
    <li>Screen neurocognitive function before transplantation for LT candidates older than 5 years and at key junctures afterward to determine special education needs (<strong>1B</strong>). </li>
    <li>Assess recipients for hearing loss in the first postoperative year and periodically thereafter as indicated (<strong>1B</strong>). </li>
    <li>Provide rehabilitation immediately after transplantation: physical therapy for infants with delayed motor development and speech and occupational therapy for older children with deficits (<strong>1B</strong>). </li>
</ol>
<p><strong>Adherence</strong></p>
<ol style="list-style-type: decimal;" start="12">
    <li>The transplant team assesses and treats nonadherence with a multidisciplinary approach (<strong>2B</strong>). </li>
    <li>Screen for nonadherence with objective methods such as the monitoring of immunosuppressant levels (<strong>1B</strong>). </li>
</ol>
<p><strong>Screening and Detection of Late Surgical Complications</strong></p>
<ol style="list-style-type: decimal;" start="14">
    <li>Surgical complications are optimally investigated and treated at a transplant center (<strong>2B</strong>). </li>
</ol>
<p><strong>Protocol Liver Biopsy</strong></p>
<ol style="list-style-type: decimal;" start="15">
    <li>Protocol liver biopsy 1 year after transplantation is not required (<strong>1B</strong>). </li>
</ol>
<p><strong>Screening for Skin Cancer</strong></p>
<ol style="list-style-type: decimal;" start="16">
    <li>Encourage protective clothing, regular screening for skin lesions, and sunscreen (<strong>1B</strong>). </li>
</ol>
<p><strong>Safe Living</strong></p>
<ol style="list-style-type: decimal;" start="17">
    <li>Minimize infection risks related to hygiene, food, water, animals/pets, and travel (<strong>2C</strong>). </li>
    <li>Recipients can travel abroad 6 months after transplantation with normal precautions and the advice of their transplant center (<strong>2C</strong>). </li>
    <li>Combat childhood infections with recombinant or killed vaccines (<strong>1A</strong>). </li>
    <li>Immunize household contacts. Recipients and relatives should receive the annual influenza immunization (<strong>1B</strong>). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Immunosuppression</span></strong></p>
<p><strong>Acute Rejection (AR)</strong></p>
<ol style="list-style-type: decimal;" start="21">
    <li>Serial measurements of bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), and immunosuppressant blood levels are the main means of detecting graft dysfunction and AR (<strong>1B</strong>) </li>
    <li>A histological assessment of a liver biopsy sample remains the best means of diagnosing AR (<strong>1A</strong>). </li>
</ol>
<p><strong>Chronic Rejection (CR)</strong></p>
<ol style="list-style-type: decimal;" start="23">
    <li>CR is a major cause of late graft loss and should be considered in the setting of poorly responsive AR with biopsy findings supportive of CR (<strong>1A</strong>). </li>
    <li>Treat CR with one of a variety of choices: use a higher serum level of the immunosuppressive (e.g., tacrolimus), switch to different immunosuppressives (e.g., from tacrolimus to mTOR inhibitors), and/or add other immunosuppressives (e.g., mycophenolate; <strong>1B</strong>). </li>
</ol>
<p><strong>Renal Function</strong></p>
<p><em>Screening and Prevention</em></p>
<ol style="list-style-type: decimal;" start="25">
    <li>Regularly screen renal function with the estimated glomerular filtration rate (eGFR) and practice calcineurin minimization. Consider renal-sparing drugs when the calculated GFR is &lt;70 mL/minute/1.73 m<sup>2</sup> (<strong>1B</strong>). </li>
</ol>
<p><strong>Diabetes Mellitus</strong></p>
<ol style="list-style-type: decimal;" start="26">
    <li>Screen LT recipients older than 5 years annually with fasting glucose in the early post-LT period and during long-term follow-up. Diagnose and treat posttransplant diabetes mellitus with the current standardized criteria (<strong>1A</strong>). </li>
</ol>
<p><strong>Cardiovascular Disease</strong></p>
<ol style="list-style-type: decimal;" start="27">
    <li>Screen recipients annually for cardiovascular risks (body mass index, blood pressure, and fasting lipids) and treat them according to age specific guidelines. Consider modifying immunosuppression regimens (<strong>1B</strong>). </li>
</ol>
<p><strong>Withdrawal of Immunosuppression</strong></p>
<ol style="list-style-type: decimal;" start="28">
    <li>Corticosteroids may be withdrawn within 6 months of transplantation for patients who receive tacrolimus as their primary immunosuppression (<strong>1B</strong>). </li>
    <li>For patients more than 1 year after transplantation with normal liver blood tests, maintain tacrolimus therapy with target immunosuppression levels &lt;6 ng/mL (<strong>1C</strong>). </li>
    <li>More than 5 years after transplantation, immunosuppression minimization (defined as a calcineurin inhibitor [CNI] once daily) may be considered if there is no history of CR, liver tests are normal, and a biopsy sample shows minimal or no portal inflammation and less than stage 3 fibrosis (<strong>2C</strong>). </li>
    <li>Complete immunosuppression withdrawal may be indicated if there are significant immune-related complications, but this should occur only within clinical trials (<strong>2C</strong>). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Disease-specific Issues and Recurrent Disease</span></strong></p>
<ol style="list-style-type: decimal;" start="32">
    <li>Be aware of the risk of recurrence of primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) in children after transplantation and the need to continue steroids (<strong>1B</strong>). </li>
    <li>Periodic screening for colon cancer after transplantation for PSC with colitis may be beneficial; the optimal intervals are unknown (<strong>2B</strong>). </li>
    <li>A multidisciplinary approach to hepatoblastoma care involving oncology, radiology, hepatology, and surgery can improve posttransplant survival (<strong>2B</strong>). </li>
    <li>Patients with cystic fibrosis require close multispecialist care after isolated LT, with particular attention paid to nutrition, lung function, and infectious risks (<strong>1A</strong>). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Infections</span></strong></p>
<p><strong>Late Viral Infections</strong></p>
<p><em>Cytomegalovirus (CMV)</em></p>
<ol style="list-style-type: decimal;" start="36">
    <li>Diagnose with quantitative nucleic acid-based or CMV pp65 antigenemia viral load assays in patients with a compatible clinical syndrome (<strong>1A</strong>). </li>
    <li>No specific prophylactic strategy is routinely indicated for CMV donor-negative/recipient-negative children, but the use of intravenous ganciclovir for all CMV donor-positive/recipient-negative recipients is recommended (<strong>1A</strong>). </li>
    <li>The primary transplant center should coordinate the management of symptomatic or asymptomatic patients with detectable CMV polymerase chain reaction and/or rising titer CMV viral loads (<strong>1B</strong>). </li>
    <li>Intravenous ganciclovir is recommended as the initial antiviral therapy; continue this until the CMV load becomes undetectable (<strong>2C</strong>). </li>
    <li>Consider ganciclovir resistance in patients with refractory clinical symptoms or children with persistent/rising CMV loads despite at least 14 days of antiviral therapy. Consider genotypic testing for resistance mutations and second-line therapies (foscarnet and cidofovir; <strong>1B</strong>). </li>
</ol>
<p><em>Epstein-Barr Virus (EBV) and Post-transplant Lymphoproliferative Disorder (PTLD)</em></p>
<ol style="list-style-type: decimal;" start="41">
    <li>Determine the EBV serostatus of recipients and donors to identify patients at high risk for PTLD (<strong>1B</strong>). </li>
    <li>Seronegative patients before transplantation should be screened with EBV viral loads annually afterward to determine their susceptibility to a primary infection. Screen recipients at increased risk for EBV disease (donor-positive/recipient-negative) and PTLD weekly or biweekly during the first year after transplantation (<strong>1B</strong>). </li>
    <li>Patients presenting with typical symptoms such as persistent fever and lymphadenopathy should be clinically evaluated for PTLD with histopathology and EBV viral loads. Those with rising EBV viral loads should be discussed with their transplant center; management might include reduced immunosuppression and/or specific therapy (<strong>1B</strong>). </li>
</ol>
<p><strong>Community-acquired Respiratory Viruses</strong></p>
<ol style="list-style-type: decimal;" start="44">
    <li>Immunize recipients against community-acquired viruses (influenza A, B) annually. No guidance exists for respiratory syncytial virus prophylaxis (<strong>1B</strong>). </li>
</ol>
<p><em>Pneumocystis jirovecii</em></p>
<ol style="list-style-type: decimal;" start="45">
    <li>Give at least 6 months' prophylaxis with trimethoprim/sulfamethoxazole (<strong>1B</strong>). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Adolescent Issues</span></strong></p>
<p><strong>Risk Behavior</strong></p>
<ol style="list-style-type: decimal;" start="46">
    <li>All adolescent girls should receive advice about fertility, contraception, and safe immunosuppression during pregnancy and should avoid mycophenolate (<strong>2B</strong>). </li>
    <li>All girls with menstrual problems should be reviewed by a gynecologist for advice and management (<strong>2C</strong>). </li>
    <li>Transfer adolescents who become pregnant to adult care to manage their immunosuppression (<strong>2B</strong>). </li>
    <li>Inquire about prospective health insurance at the age of 17 to 19 years (depending on the locale; <strong>2B</strong>). </li>
    <li>Discuss the avoidance of substance abuse and smoking, advise minimal alcohol intake, and review risky behaviors annually (<strong>2C</strong>). </li>
</ol>
<p><strong>Transition to Adult Care</strong></p>
<ol style="list-style-type: decimal;" start="51">
    <li>The transition process is multidisciplinary and should begin around the age of 10 to 11 years according to developmental maturity (<strong>2B</strong>). </li>
    <li>Prepare a standard transition protocol involving pediatric and adult providers (<strong>2B</strong>). </li>
    <li>Before the transfer, achieve readiness by building the patient's understanding of the illness, self-management skills, and ability to assume responsibility over his or her care (<strong>2B</strong>). </li>
    <li>Identify an adult care group to work closely with the transferring pediatrician and the patient for at least 1 year before the transfer (<strong>2C</strong>). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Strength of Recommendation*</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Strength of Recommendation">
    <thead>
        <tr>
            <th valign="top">Strength of Recommendation</th>
            <th valign="top">Criteria</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">
            <ol style="list-style-type: decimal;" start="1">
                <li>Strong </li>
            </ol>
            </td>
            <td valign="top">Factors influencing the strength of the recommendation include the quality of the evidence, the presumed patient-important outcomes, and the cost.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: decimal;" start="2">
                <li>Weak </li>
            </ol>
            </td>
            <td valign="top">There is variability in the preferences and values or more uncertainty. The recommendation is made with less certainty, or the cost or resource consumption is higher.</td>
        </tr>
    </tbody>
</table>
<p><strong>Quality of Evidence*</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Quality of Evidence">
    <thead>
        <tr>
            <th valign="top">Quality of Evidence</th>
            <th valign="top">Criteria</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="1">
                <li>High </li>
            </ol>
            </td>
            <td valign="top">Further research is unlikely to change confidence in the estimate of the clinical effect.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="2">
                <li>Moderate </li>
            </ol>
            </td>
            <td valign="top">Further research may change confidence in the estimate of the clinical effect.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="3">
                <li>Low </li>
            </ol>
            </td>
            <td valign="top">Further research is very likely to affect confidence in the estimate of the clinical effect.</td>
        </tr>
    </tbody>
</table>
<p class="Note">*Classification used by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) workgroup with minor modifications.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Any condition requiring liver transplantation</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Management</p>
                    <p>Prevention</p>
                    <p>Screening</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Gastroenterology</p>
                    <p>Infectious Diseases</p>
                    <p>Nephrology</p>
                    <p>Pediatrics</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To provide expert consensus on managing children from 3 months after liver transplant</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Children and adolescents who have undergone liver transplantation</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>Optimization of nutritional status </li>
    <li>Monitoring of potential growth impairment (minimization of steroid exposure, measurement of height and weight) </li>
    <li>Monitoring of body mass index and obesity management </li>
    <li>Monitoring for persistent hepatic osteodystrophy, risk factors for fractures, and scoliosis </li>
    <li>Vitamin supplementation </li>
    <li>Assessment of school functioning and absence </li>
    <li>Psychiatric assessment for post-traumatic stress disorder or other mental health issues </li>
    <li>Screening of neurocognitive function </li>
    <li>Assessment for hearing loss </li>
    <li>Physical rehabilitation </li>
    <li>Speech and occupational therapy </li>
    <li>Screening for nonadherence </li>
    <li>Screening for surgical complications </li>
    <li>Encouraging protective clothing, screening for skin lesions, and use of sunscreen </li>
    <li>Minimizing infection risks (hygiene, food, water, animals/pets, travel) </li>
    <li>Travel precautions </li>
    <li>Vaccination of transplant recipient and household contacts </li>
    <li>Screening for and treatment of acute rejection (AR) and chronic rejection (CR)
    <ul style="list-style-type: disc;">
        <li>Serial measurement of bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), and immunosuppressant blood levels </li>
        <li>Histological assessment of liver biopsy sample </li>
        <li>Use of immunosuppressive therapy (e.g., tacrolimus, mTOR inhibitors, mycophenolate) </li>
    </ul>
    </li>
    <li>Screening and treatment of complications: renal function, diabetes mellitus, cardiovascular disease </li>
    <li>Withdrawal of immunosuppression </li>
    <li>Management of disease-specific issues and recurrent disease </li>
    <li>Diagnosis and management of infections (e.g., cytomegalovirus [CMV], Epstein-Barr virus [EBV] and posttransplant lymphoproliferative disorder [PLTD], <em>Pneumocystis jirovecii</em>) </li>
    <li>Special management of adolescent issues, including sexuality and sexually transmitted diseases, menstrual abnormalities, contraception, pregnancy, and nonadherence </li>
    <li>Transition to adult care and self-management </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Long term morbidity and mortality </li>
    <li>Quality of life </li>
    <li>Adverse effects of treatments </li>
    <li>Prevention and management of early postoperative complications </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>These recommendations are based on a formal review and analysis of recently published world literature on the topic (PubMed/MEDLINE search from 1996 through 2011), limited to the English language, human studies, and children 0-18 years old.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Expert Consensus</p>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Quality of Evidence*</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Quality of Evidence">
    <thead>
        <tr>
            <th valign="top">Quality of Evidence</th>
            <th valign="top">Criteria</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="1">
                <li>High</li>
            </ol>
            </td>
            <td valign="top">Further research is unlikely to change confidence in the estimate of the clinical effect.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="2">
                <li>Moderate</li>
            </ol>
            </td>
            <td valign="top">Further research may change confidence in the estimate of the clinical effect.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: upper-alpha;" start="3">
                <li>Low</li>
            </ol>
            </td>
            <td valign="top">Further research is very likely to affect confidence in the estimate of the clinical effect.</td>
        </tr>
    </tbody>
</table>
<p class="Note">*Classification used by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) workgroup with minor modifications.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>These recommendations are based on the following: (1) a formal review and analysis of recently published world literature on the topic; (2) <em>A Manual for Assessing Health Practices and Designing Practice Guidelines from the American College of Physicians</em>; (3) guideline policies, including the American Association for the Study of Liver Diseases policy on the development and use of practice guidelines and the American Gastroenterological Association policy statement on the use of medical practice guidelines; and (4) the experience of the authors in managing children undergoing liver transplantation (LT).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Strength of Recommendation*</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Strength of Recommendation">
    <thead>
        <tr>
            <th valign="top">Strength of Recommendation</th>
            <th valign="top">Criteria</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">
            <ol style="list-style-type: decimal;" start="1">
                <li>Strong</li>
            </ol>
            </td>
            <td valign="top">Factors influencing the strength of the recommendation include the quality of the evidence, the presumed patient-important outcomes, and the cost.</td>
        </tr>
        <tr>
            <td valign="top">
            <ol style="list-style-type: decimal;" start="2">
                <li>Weak</li>
            </ol>
            </td>
            <td valign="top">There is variability in the preferences and values or more uncertainty. The recommendation is made with less certainty, or the cost or resource consumption is higher.</td>
        </tr>
    </tbody>
</table>
<p class="Note">*Classification used by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) workgroup with minor modifications.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>External Peer Review</p>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>This practice guideline was produced in collaboration with the Practice Guidelines Committee of the American Association for the Study of Liver Diseases, which provided extensive peer review of the manuscript. An external review was provided by Miriam B. Vos, M.D., M.S.P.H.</p>
<p>This guideline has been approved by the American Association for the Study of Liver Diseases and the American Society of Transplantation, and it has been endorsed by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Appropriate and effective long-term medical management of the pediatric patient after liver transplantation</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Two-thirds of late deaths can be attributed to complications of immunosuppression, infections, and malignancies. Immunosuppression medications are associated with an increased risk for diabetes, hyperlipidemia, hypertension, obesity, and metabolic syndrome. Long-term immunosuppression treatment incurs substantial complications. The minimization or withdrawal of immunosuppression should be managed cautiously to prevent allograft damage. </li>
    <li>Early infectious complications tend to be related to surgical manipulations, technical complications of the surgery, and catheters and other foreign bodies. Intermediate infections are more attributable to immunosuppression, which risks infections with opportunistic pathogens (cytomegalovirus [CMV] and <em>Pneumocystis jirovecii</em>) as well as potentially severe disease from community-acquired pathogens (respiratory syncytial virus and influenza viruses). Children with uncorrected surgical complications (bile duct stenosis and obstructions) may suffer recurrent bacterial disease. </li>
    <li>Avascular necrosis is a complication of high-dose steroid treatments and has been reported in 7 of 196 solid organ transplant recipients (3.6%) 9.2 years after transplantation. </li>
    <li>Complications of liver biopsy are relatively rare, but 2% to 5% of children may have a significant complication (usually postbiopsy bleeding). </li>
    <li>Other adverse effects of treatments include hirsutism, obesity, and gingival hyperplasia. </li>
    <li>Calcineurin inhibitors (CNI), the principal immunosuppressive medications used to prevent graft rejection, contribute to de novo acute and chronic posttransplant renal dysfunction. </li>
</ul></p>

            </div>
                <h2 id="430" class="accordion-title section-430 is-active" role="tab" aria-expanded="true"><a href="#">Contraindications</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Contraindications</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>If treatment is required for late hepatic artery thrombosis, thrombolysis and anticoagulation are rarely effective, and surgical reconstruction is contraindicated. </li>
    <li>Chronic rejection (CR), hepatic artery thrombosis (HAT) or portal vein thrombosis (PVT) may contraindicate a repair of incisional hernia. </li>
    <li>Live attenuated vaccines are generally contraindicated after transplantation. Varicella vaccination is not recommended in children receiving long-term immunosuppression. </li>
    <li>All adolescent girls should avoid mycophenolate. </li>
</ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, Farmer D, Shemesh E, McDonald RA. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013 Aug;19(8):798-825. [321 references] <a href="https://web.archive.org/web/20180712204052/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23836431" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712204052im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2013 Aug</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American Association for the Study of Liver Diseases - Nonprofit Research Organization</p>
                    <p>American Society of Transplantation - Professional Association</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>Financial support for the development of this guideline was provided by the American Association for the Study of Liver Diseases (AASLD).</p>
<p>AASLD does not accept corporate support for the development of practice guidelines. However, AASLD gratefully acknowledges the support of Genentech and Merck for providing independent medical education grants for mobile download applications for AASLD practice guidelines.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Practice Guidelines Committee</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Primary Authors</em>: Deirdre A. Kelly, Liver Unit, Birmingham Children's Hospital, National Health Service Trust, Birmingham, United Kingdom; John C. Bucuvalas, Integrated Solid Organ Transplant Program, Cincinnati Children's Hospital, Cincinnati, OH; Estella M. Alonso, Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital, Chicago, IL; Saul J. Karpen, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Emory Children's Center, Atlanta, GA; Upton Allen, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada; Michael Green, Division of Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, PA; Douglas Farmer, Dumont-UCLA Transplant Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; Eyal Shemesh, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY; Ruth A. McDonald, Division of Pediatric Nephrology, Seattle Children's Hospital, Seattle, WA</p>
<p><em>Committee Members</em>: Jayant A. Talwalkar, M.D., M.P.H. (<em>Chair</em>); Keith D. Lindor, M.D. (governing board liaison for the American Association for the Study of Liver Diseases); Sumeet Asrani, M.D.; Hari S. Conjeevaram, M.D., M.S.; David A. Gerber, M.D.; Marlyn J. Mayo, M.D.; Raphael B. Merriman, M.D., M.R.C.P.; Gerald Y. Minuk, M.D.; Alexander Monto, M.D.; Michael K. Porayko, M.D.; Benjamin L. Shneider, M.D.; Tram T. Tran, M.D.; Helen S. Yee, Pharm.D.</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Endorser(s)</a></h3>
                    <p>North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition - Professional Association</p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180712204052/https://www.guideline.gov/Home/Disclaimer?id=47151&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.aasld.org%2fpracticeguidelines%2fDocuments%2flt23697.pdf" title="American Association for the Study of Liver Diseases Web site">American Association for the Study of Liver Diseases Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204052im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p>
<p>Print copies: Available from the American Association for the Study of Liver Diseases, 1729 King Street, Suite 200; Alexandria, VA 22314; Phone: 703-299-9766; Web site: <a href="/web/20180712204052/https://www.guideline.gov/Home/Disclaimer?id=47151&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.aasld.org" title="American Association for the Study of Liver Diseases Web site">www.aasld.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204052im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>; e-mail: <a href="https://web.archive.org/web/20180712204052/mailto:aasld@aasld.org">aasld@aasld.org</a>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This summary was completed by ECRI Institute on December 13, 2013.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the American Association for the Study of Liver Diseases' copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712204052/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712204052/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712204052/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204052/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204052/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204052/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204052/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204052/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712204052/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712204052/https://www.guideline.gov/disclaimer?id=47151&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712204052/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712204052/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712204052/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712204052/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712204052/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712204052/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712204052/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712204052/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712204052/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712204052/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712204052/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712204052/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712204052/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712204052im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712204052/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712204052/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712204052js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712204052js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:40:52 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:36:41 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 75.826 (3)
  esindex: 0.011
  captures_list: 138.679
  CDXLines.iter: 41.102 (3)
  PetaboxLoader3.datanode: 70.786 (4)
  exclusion.robots: 0.354
  exclusion.robots.policy: 0.327
  RedisCDXSource: 11.31
  load_resource: 36.402
-->